Morepen Laboratories Limited
MOREPENLAB
LTP
N/A
Latest Quarter Update
Historic Growth Fuels Future Potential Record profits and strategic expansion
Profit After Tax
INR 36 crores, up 147% YoY
Successful QIP raised INR 200 crores for capacity expansion
Medical devices revenue grew 20% YoY
Plans to enhance export capabilities for medical devices
Earning Calls History
Q1 FY2025 - August 14, 2024
Latest
Morepen Laboratories reported a historic Q1 FY '25 with record EBITDA and profit margins. The successful completion of a QIP has strengthened institutional holdings and positioned the company for growth in the medical devices and API sectors.
Q3 FY2024 - February 01, 2024
Morepen Laboratories reported a robust Q3 FY2024 with substantial growth across key financial metrics. The company achieved significant improvements in revenue, EBITDA, and profit margins, reflecting effective operational strategies and market expansion. Management expressed optimism about sustaining this momentum moving forward.
Q2 FY2024 - November 03, 2023
Morepen Laboratories Limited reported a robust Q2 FY24, showcasing a 5% increase in revenue and a remarkable 34% rise in profit after tax. The company is experiencing stabilized growth across its segments, particularly in medical devices and APIs.